Ultrasound-enhanced stenosis therapy

• US 20110082534A1
• Filed: 08/27/2010
• Published: 04/07/2011
• Est. Priority Date: 10/06/2009
• Status: Abandoned Application

• Current Assignee: CardioProlific Inc. (Koninklijke Philips N.V.)
• Original Assignee: CardioProlific Inc. (Koninklijke Philips N.V.)
• Inventors: Wallace, Michael P.
• Application Number:
  US12/807,129
• Publication Number:
  US 20110082534A1
• Time in Patent Office: Days
• US Class Current: 623/1.11
• CPC Class Codes: A61B 17/22004 using mechanical vibrations, e.g. ultrasonic shock waves A61B17/225 takes precedence
• CPC Class Codes: A61B 17/22012 in direct contact with, or very close to, the obstruction or concrement for removing obstructions in blood vessels by laser A61B18/245
• CPC Class Codes: A61B 18/02 by cooling, e.g. cryogenic techniques devices for cooling specific reflex points of the body within cell-life limits A61H39/06
• CPC Class Codes: A61B 2018/00029 open
• CPC Class Codes: A61B 2018/0212 using an instrument inserted into a body lumen, e.g. catheter
• CPC Class Codes: A61M 25/00 Catheters; Hollow probes dilators A61M29/00; peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00 ; for measuring or testing A61B; materials for catheters A61L29/00
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
• CPC Class Codes: A61N 2007/0043 intra-cavitary

Abstract

Apparatus and methods are disclosed for vascular stenosis therapy, including enhancing permeability of the vessel wall using ultrasound energy and delivering a therapeutic agent into the arterial wall. Ultrasound energy may also be delivered using transcutaneous techniques and endovascular methods. In some embodiments, ultrasound energy and therapeutic agent application may be combined with angioplasty techniques and with blood flow protection devices to prevent dissipation of the therapeutic agent from the treatment site.

Claims

1. A method for treating stenosis or inhibiting restenosis in an artery by delivering a therapeutic agent into the artery and enhancing absorption of the therapeutic agent into a wall of the artery using ultrasound energy, the method comprising:

emitting ultrasound energy from the ultrasound catheter, and

delivering a stenosis inhibiting therapeutic agent into the artery from the ultrasound catheter.

2. The method of claim 1, wherein the frequency of the ultrasonic energy is no more than about 100 kHz and the power delivered from the distal end of the ultrasound catheter is no more than about 20 watts.

3. The method of claim 1, wherein the therapeutic agent is delivered to the vessel wall after the vessel wall is exposed to ultrasound energy.

4. The method of claim 1, wherein the therapeutic agent is an agent selected from the group consisting of:

liquid, powder, particle, microbubbles, microspheres, nanospheres, liposomes and combinations thereof.

5. The method of claim 1, further comprising positioning a blood flow protection device within the artery to prevent the therapeutic agent from flowing downstream and further removing the drug residue from the body.

6. The method of claim 1, further including the step of providing an ultrasound transmission member in the ultrasound catheter, the ultrasound transmission member propagating ultrasound energy from an ultrasound transducer located on the proximal end of the catheter outside the body to the distal end of the catheter.

7. The method of claim 1, further comprising performing an angioplasty procedure before delivery of ultrasound energy and the therapeutic agent, wherein the angioplasty procedure is selected from the group consisting of:

balloon angioplasty, stent placement, atherectomy, laser angioplasty, cryoplasty and combination procedures.

8. The method of claim 1, further comprising performing an angioplasty procedure during delivery of ultrasound energy and the therapeutic agent, wherein the angioplasty procedure is selected from the group consisting of:

balloon angioplasty, stent placement, atherectomy, laser angioplasty, cryoplasty and combination procedures.

9. The method of claim 1, further comprising performing an angioplasty procedure after delivery of ultrasound energy and the therapeutic agent, wherein the angioplasty procedure is selected from the group consisting of:

balloon angioplasty, stent placement, atherectomy, laser angioplasty, cryoplasty and combination procedures.

10. A method for treating stenosis or inhibiting restenosis in an artery by delivering a therapeutic agent into the artery and enhancing absorption of the therapeutic agent into a wall of the artery using ultrasound energy, the method comprising:

emitting the ultrasound energy from the ultrasound catheter and

delivering a stenosis inhibiting therapeutic agent into the artery from a separate drug delivery catheter.

11. The method of claim 10, wherein the therapeutic agent is delivered to the vessel wall according to one method from the group consisting of:

before ultrasound energy delivery, during ultrasound energy delivery, and after ultrasound energy delivery.

12. A method for treating stenosis or inhibiting restenosis at a treatment location in an artery, comprising the steps of:

enhancing permeability of the vessel wall via the delivery of ultrasound energy to the treatment location, and

delivering a therapeutic agent into the artery to the treatment location.

13. The method of claim 12, wherein ultrasound energy is delivered to the treatment area using transcutaneous methods.

14. The method of claim 12, wherein ultrasound energy is delivered to the treatment area using endovascular methods.

15. The method of claim 12, wherein the therapeutic agent is delivered to the vessel wall according to one method selected from the group consisting of:

before ultrasound energy delivery, during ultrasound energy delivery, and after ultrasound energy delivery.

16. The method of claim 12, wherein treating stenosis and inhibiting restenosis includes treating vulnerable plaque in an artery.

17. The method of claim 12, wherein treating stenosis or inhibit re-stenosis in the artery involves ablating or removing plaque or thrombotic material.

18. The method of claim 12, wherein treating stenosis or inhibiting restenosis involves treating a totally occluded artery.

19. The method of claim 12, further comprising positioning a blood flow limitation device within the artery to prevent the therapeutic agent from a quick washout by the blood.